These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8192534

  • 1. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
    Janicka L, Ksiazek A, Baranowicz I, Mierzicki P.
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():67-77. PubMed ID: 8192534
    [Abstract] [Full Text] [Related]

  • 2. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M, Bartlett DK, Brier ME, Golper TA.
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [Abstract] [Full Text] [Related]

  • 3. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
    Monnerat C, Leyvraz S.
    Praxis (Bern 1994); 1999 Jan 28; 88(5):178-88. PubMed ID: 10067375
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A, Paoletti E, Molinelli G.
    Adv Perit Dial; 1990 Jan 28; 6():292-5. PubMed ID: 1982830
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr 28; 24(142):312-5. PubMed ID: 18634362
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
    Salmonson T.
    Scand J Urol Nephrol Suppl; 1990 Apr 28; 129():1-66. PubMed ID: 2255869
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K, Lubom JA, Collier L, Fleming D, Work J.
    Adv Perit Dial; 1994 Apr 28; 10():124-8. PubMed ID: 7999809
    [Abstract] [Full Text] [Related]

  • 10. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Apr 28; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 11. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats.
    Kozioł M, Ksiazek P, Feldo M, Spasiewicz D, Michalak J, Kleinrok Z.
    Ann Univ Mariae Curie Sklodowska Med; 1994 Apr 28; 48 Suppl 3():61-6. PubMed ID: 8192533
    [Abstract] [Full Text] [Related]

  • 12. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity.
    Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Riñon C, Sanchez Sicilia L.
    Adv Perit Dial; 1991 Apr 28; 7():296-300. PubMed ID: 1680450
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of subcutaneous erythropoietin in CAPD patients.
    Piraino B, Johnston JR.
    Clin Nephrol; 1990 Apr 28; 33(4):200-2. PubMed ID: 2350907
    [Abstract] [Full Text] [Related]

  • 15. Erythropoietin response and route of administration.
    Taylor JE, Belch JJ, Fleming LW, Mactier RA, Henderson IS, Stewart WK.
    Clin Nephrol; 1994 May 28; 41(5):297-302. PubMed ID: 8050210
    [Abstract] [Full Text] [Related]

  • 16. [Effect of recombinant human erythropoietin (rHu-EPO) on anemia and selected biochemical parameters in patients in the pre-dialysis period].
    Sułowicz W, Drozdz M, Hanicki Z, Kraśniak A, Kuźniewski M.
    Przegl Lek; 1992 May 28; 49(1-2):50-3. PubMed ID: 1455007
    [Abstract] [Full Text] [Related]

  • 17. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M, Boguszewska-Baczkowska A, Jelonek A.
    Pol Tyg Lek; 1992 May 28; 49(6-7):135-6. PubMed ID: 8090665
    [Abstract] [Full Text] [Related]

  • 18. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D.
    Clin Nephrol; 1997 Jul 28; 48(1):1-8. PubMed ID: 9247771
    [Abstract] [Full Text] [Related]

  • 19. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S.
    Int Urol Nephrol; 1993 Jul 28; 25(2):197-203. PubMed ID: 8365853
    [Abstract] [Full Text] [Related]

  • 20. [Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial].
    Kubota M, Kawaguchi Y, Nomoto Y, Tsuchida H, Nihei H, Kubo K, Omori Y, Babazono T, Ogura Y, Hara S.
    Nihon Jinzo Gakkai Shi; 1993 Sep 28; 35(9):1081-90. PubMed ID: 8230819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.